Zydus Lifesciences Limited

Form 483 issued March 27, 2024 · Matoda, India

Inspection
Mar 18 – Mar 27, 2024
Observations
4
Pages
6
FEI number
3007621329

In short: On March 27, 2024, FDA issued a Form 483 with 4 observations to Zydus Lifesciences Limited in Matoda, India (FEI 3007621329) after an inspection that ran Mar 18 – Mar 27, 2024. The investigators were Lori M. Newman and Sean R. Marcsisin. Most observations concern facilities & equipment and production.

At a glance

3 of 4 observations on this 483 concern facilities & equipment.

Facilities & equipment3
Production1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Aseptic processing areas are deficient regarding the system…

  2. 02

    Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are…

  3. 03

    Buildings used in the manufacturing, processing, packing and holding of a drug product are not maintained…

  4. 04

    Equipment and utensils are not cleaned and maintained at appropriate intervals to prevent contamination that would…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Zydus Lifesciences Limited?

FDA listed 4 observations on this Form 483, mostly about facilities & equipment and production. The opening words of each observation are shown on this page.

Who inspected Zydus Lifesciences Limited?

Lori M. Newman and Sean R. Marcsisin are named on this Form 483, for the inspection of Mar 18 – Mar 27, 2024. Each investigator has a profile showing what they cite most.

When was Zydus Lifesciences Limited inspected by FDA?

The inspection ran Mar 18 – Mar 27, 2024, and the Form 483 is dated March 27, 2024.

How do I get the full Form 483 for Zydus Lifesciences Limited?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free